Balanced news tone
News Sentiment
LALPATHLAB sentiment intelligence
Dr. Lal PathLabs Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
25 relevant articles
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
+2.1% over one week, +0.3% over four weeks, trend active, and near fair-value range.
Dr. Lal PathLabs' Volume Boom Comes at a Cost
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
82/100 classification
One-week reaction
2.1%
Price confirming higher
Trend fit
Trend active
0.3% over four weeks
Fair value
18.3%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
4
Neutral
19
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
marketscreener.com
Direct company coverage
Dr. Lal PathLabs' Volume Boom Comes at a Cost
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 09:49
- Source
- marketscreener.com
Business Standard
Direct company coverage
Dr Lal PathLabs rises 6% in four sessions
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 09:02
- Source
- Business Standard
Business Standard
Direct company coverage
Dr Lal PathLabs soars 11%, hits 52-week high on huge volumes; here's why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 06:54
- Source
- Business Standard
Moneycontrol.com
Direct company coverage
Dr Lal PathLabs surges 9% as it forays into Dubai market with new subsidiary
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jun 2026 05:13
- Source
- Moneycontrol.com
The Economic Times
Direct company coverage
Dr. Lal Pathlabs among 5 stocks showing bullish RSI upswing
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- The Economic Times
Moneycontrol.com
Direct company coverage
Buy Dr Lal Pathlabs; target of Rs 1740: Emkay Global Financial
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 04 May 2026 07:00
- Source
- Moneycontrol.com
Equitymaster
Direct company coverage
DR. LAL PATHLABS Share Price Today Up 15%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Equitymaster
Moneycontrol.com
Direct company coverage
Momentum Stocks: Dr Lal PathLabs, JHS Svendgaard, Dar Credit rally on sheer momentum
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 04 May 2026 07:00
- Source
- Moneycontrol.com
Business Standard
Direct company coverage
Dr. Lal PathLabs jumps after Q4 results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- Business Standard
NDTV Profit
Direct company coverage
Dr Lal Pathlabs Sees Target Price Cut From ICICI Securities After Q4 Results — Here's Why
- Tone
- Negative 42/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- NDTV Profit
simplywall.st
Direct company coverage
Here's What Analysts Are Forecasting For Dr. Lal PathLabs Limited (NSE:LALPATHLAB) After Its Yearly Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 May 2026 07:00
- Source
- simplywall.st
scanx.trade
Direct company coverage
Dr. Lal PathLabs Q4FY26 Results: Revenue Grows, Profit Declines, Dividend Approved
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 May 2026 07:00
- Source
- scanx.trade
marketscreener.com
Direct company coverage
Dr. Lal Pathlabs Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 30 Apr 2026 07:00
- Source
- marketscreener.com
Moneycontrol.com
Direct company coverage
Dr Lal PathLabs readies a war chest for southern push as CFO Goel flags potential big‑ticket M&A,...
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Feb 2026 08:00
- Source
- Moneycontrol.com
simplywall.st
Direct company coverage
After the recent decline, Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Top Key Executive Arvind Lal's holdings have lost 3.1% of their value
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 21 Jan 2026 08:00
- Source
- simplywall.st
CNBC TV18
Direct company coverage
Dr. Lal Pathlabs Ltd. Share Price Live Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jan 2026 14:51
- Source
- CNBC TV18
simplywall.st
Direct company coverage
Here's Why We Think Dr. Lal PathLabs (NSE:LALPATHLAB) Might Deserve Your Attention Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jan 2026 08:00
- Source
- simplywall.st
The Economic Times
Direct company coverage
Dr Lal PathLabs shares tank 51% today, but here’s why investors shouldn’t panic
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Dec 2025 08:00
- Source
- The Economic Times
Goodreturns
Direct company coverage
Bonus Shares Incoming! Dr. Lal PathLabs Makes It Official; Key Dates Inside For 1:1 Bonus Issue Purpose
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Dec 2025 08:00
- Source
- Goodreturns
simplywall.st
Direct company coverage
Dr. Lal PathLabs (NSE:LALPATHLAB) Could Become A Multi-Bagger
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Dec 2025 08:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Nov 2025 07:00
- Source
- simplywall.st
Upstox
Direct company coverage
Dr Lal PathLabs Q2: Company declares 2nd interim dividend, bonus share in 1:1 ratio; check all details
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 31 Oct 2025 07:00
- Source
- Upstox
simplywall.st
Direct company coverage
Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 18 Aug 2025 07:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Shares May Have Run Too Fast Too Soon
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jul 2025 07:00
- Source
- simplywall.st
StockInvest.us
Direct company coverage
LALPATHLAB.NS - Dr. Lal PathLabs Limited Company Profile
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Aug 2020 19:07
- Source
- StockInvest.us